HAEMATO AG (XTER:HAEK) Price-to-Tangible-Book : 1.92 (As of May. 12, 2024)

View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Price-to-Tangible-Book?

As of today (2024-05-12), HAEMATO AG's share price is €21.40. HAEMATO AG's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was €11.12. Hence, HAEMATO AG's Price to Tangible Book Ratio of today is 1.92.

The historical rank and industry rank for HAEMATO AG's Price-to-Tangible-Book or its related term are showing as below:

XTER:HAEK' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.22 Med: 3.37 Max: 6.15
Current: 1.35

During the past 13 years, HAEMATO AG's highest Price to Tangible Book Ratio was 6.15. The lowest was 1.22. And the median was 3.37.

XTER:HAEK's Price-to-Tangible-Book is ranked better than
76% of 871 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs XTER:HAEK: 1.35

A closely related ratio is called PB Ratio. As of today, HAEMATO AG's share price is €21.40. HAEMATO AG's Book Value per Sharefor the quarter that ended in Jun. 2023 was €28.58. Hence, HAEMATO AG's P/B Ratio of today is 0.75.

HAEMATO AG Price-to-Tangible-Book Historical Data

The historical data trend for HAEMATO AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Price-to-Tangible-Book Chart

HAEMATO AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.87

1.98

1.25

2.34

1.61

HAEMATO AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.58	2.34	2.05	1.61	2.09

Competitive Comparison of HAEMATO AG's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HAEMATO AG's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's Price-to-Tangible-Book falls into.

HAEMATO AG Price-to-Tangible-Book Calculation

HAEMATO AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	21.40	/	11.124
	=	1.92

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

HAEMATO AG Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG (XTER:HAEK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

HAEK:Germany HAEK:Germany HAEK:Germany

Address

Lilienthalstrasse 5c, Schonefeld, DEU, D-12529

Website

https://www.haemato.ag

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines